bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Addiction associated N40D mu-opioid receptor variant modulates synaptic function in
human neurons
Apoorva Halikere1,2, Dina Popova1,2, Aula Hamod1,2, Mavis R. Swerdel5, Jennifer C. Moore3,4,
Jay A. Tischfield3,4, Ronald P. Hart3,5, Zhiping P. Pang1,2,3*
1
Child Health Institute of New Jersey, 2Department of Neuroscience and Cell Biology, Rutgers
Robert Wood Johnson Medical School, 3Human Genetics Institute of New Jersey, 4Department
of Human Genetics, 5 Department of Cell Biology and Neuroscience, Rutgers University
*Correspondence to:
Zhiping Pang,
Child Health Institute of New Jersey, Rutgers University,
89 French Street, Room 3277
New Brunswick, NJ 08901,
Phone: (732)-235-8074, Fax: (732)-235-8612,
Email: zhiping.pang@rutgers.edu
Running title: Functional impact of N40D MOR variants in human neurons
Keywords: induced pluripotent stem cells; human neurons; induced neurons, addiction; gene
variants; synaptic transmission
Number of words in the abstract: 249
Number of words in the main text: 3454
Number of figures: 4
Supplementary information: 1
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Abstract
Background: The OPRM1 A118G gene variant (N40D) encoding the µ-opioid receptor
(MOR) has been associated with dependence on opiates and other abused drugs but its
mechanism is unknown. With opioid abuse-related deaths rising at unprecedented rates,
understanding these mechanisms may provide a path to therapy.
Methods: Seven human induced pluripotent stem (iPS) cell lines from homozygous
N40D subjects (4 with N40 and 3 with D40 variants) were generated and human induced
neuronal cells (iNs) were derived from these iPS cell lines.
Morphological, gene
expression as well as synaptic physiology analyses were conducted in human iN cells
carrying N40D MOR variants; Two pairs of isogenic pluripotent stem cells carrying N40D
were generated using CRISPR/Cas9 genome-editing and iN cells derived from them
were analyzed.
Results: Inhibitory human neurons generated from subjects carrying N40D MOR gene
variants show mature properties in morphological and functional analyses. Gene
expression revealed that they express mature neuronal marker and MORs. Activation of
MORs suppressed inhibitory synaptic transmission in human neurons carrying both N40
or D40 MOR variants but D40 show stronger effects. To mitigate the confounding effects
of background genetic variation on neuronal function, the regulatory effects of MORs on
synaptic transmission were validated in two sets of independently generated isogenic
N40D iNs.
Conclusions: Activations of N40D MOR variants show different regulatory effects on
synaptic
transmission
in
inhibitory
human
neurons.
This
study
identifies
neurophysiological differences between human MOR variants that may predict altered
opioid responsivity and/or dependence in this subset of individuals.
2
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
INTRODUCTION
Well over 46,000 Americans died of opioid overdose in 2016, with the sharp increase in
2014 – 2016 due to synthetic opioids (1), prompting a public health crisis whose biological
underpinnings are poorly understood. The µ-opioid receptor (MOR) mediates the most powerful
addictive properties of abused opiate alkaloids and much research has identified chemically
diverse ligands of varying efficacies for pain relief or treatment of addiction. Because of its
substantive role in mediating reward and positive reinforcement, MOR is also an indirect target
of alcohol, nicotine, and other drugs of abuse (2, 3). MOR-mediated synaptic alterations in
reward-associated brain regions may represent a key underlying mechanism of reinforcement in
drug abuse (4), but our understanding of this process in human neurons is limited.
Human genetic studies suggest that MOR gene variants play key roles in susceptibility
to opioid addiction in humans. Most prominently, the A118G single nucleotide polymorphism
(SNP) in OPRM1, rs1799971, a non-synonymous gene variant which replaces asparagine at
position 40 (N40) with aspartate (D40), is found in up to 50% of individuals in certain ethnic
groups and is associated with drug dependence phenotypes (5). There have been a number of
investigations (5-13) into the functional consequences of the MOR D40 variant on receptor
activation in overexpression models, knock-in mice, and primate models, but no systematic
investigations into the functional and electrophysiological consequences of OPRM1 A118G
have been reported, specifically not in a human neuronal context. Understanding how the D40
variant affects MOR signaling and synaptic function when expressed at normal levels in human
neurons may provide insight into mechanisms underlying drug abuse, at least in people carrying
this variant.
In order to fill the gap in studies done in the mouse and heterologous systems, we
generated human induced neuronal (iN) cells from induced pluripotent stem (iPS) cells derived
from subjects carrying homozygous alleles for either MOR N40 or D40 in order to better dissect
3
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
the role of MOR N40D in a physiologically relevant and human-specific model system.
Strikingly, we found that D40 MOR human neurons exhibit a stronger suppression of inhibitory
synaptic release in the presence of MOR-specific agonist DAMGO ([D-Ala2, N-MePhe4, Gly-ol]enkephalin) compared to N40 human neurons. In order to control for the possibility of individual
genetic background variation between subject cell lines, we used CRISPR/Cas9 gene targeting
to generate two sets of isogenic human stem cell lines: one pair with a 118GG knock-in into a
well-characterized human embryonic stem (ES) cell line and the other by converting a minor
allele carrier (118GG, D40) into a major allele carrier (118AA, N40). Remarkably, the synaptic
regulations of MOR activation in the isogenic lines recapitulate those of neurons generated from
different human subjects. This study exemplifies the use of patient-specific iPS cells as well as
gene targeted isogenic stem cell lines to advance our understanding of the fundamental cellular
and synaptic alterations associated with MOR N40D in human neuronal context.
METHODS AND MATERIALS
Generation of human iPS cells from lymphocytes of subjects carrying MOR N40D
Human iPS cell lines were generated by RUCDR Infinite Biologics ® from human primary
lymphocytes carrying either MOR N40 or D40 genotypes using Sendai viral vectors
(CytoTuneTM, ThermoFisher Scientific), as previously described (14). Human iPS cells were
cultured and maintained as described previously (15).
Human iPS cell maintenance
Human iPS cells were cultured in 37°C, 5% CO2 on Matrigel® Matrix (Corning Life Sciences)coated plates in mTeSR medium (Stem Cell Technologies). For passaging and differentiation
done weekly, iPS cells were dissociated using Accutase (Stem Cell Technologies), spun down
4
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
at 1000 RPM for 5 minutes, and replated at a density of 20,000 cells/cm 2 for maintenance
cultures and 50,000 cells/cm 2 for differentiation.
Lentivirus preparation
Lentiviruses were produced in HEK293T cells by co-transfection of the three envelope proteins
REV, RRE and VSVG vectors with 22µg of either FUW-Tet-O-Ascl1-T2A-puromycin, FUW-TetO-Dlx2-IRES-hygromycin, or FUW-rtTA. For each transfection, 9.1µg of REV, 13.77 µg VsVg,
19.1 µg RRE with 22g of lentiviral vector was transfected into a 150mm dish of HEK293T cells
of 60% confluency using calcium phosphate transfection technique. Media was changed 12
hours following transfection, and virus was harvested in the media 48 hours following
transfection, pelleted using an ultra-centrifuge (25,000 RPM for 2 hours), resuspended in MEM
and aliquoted. Virus was stored in -80°C until use.
Generations of isogenic human stem cell lines carrying N40D MOR gene variants
Two pairs of isogenic N40D MOR human stem cells lines were generated using CRISPR/Cas9
genome editing. Briefly, to convert H1 embryonic stem (ES) cells carrying homozygous AA118
major allele to GG118 homozygous minor alleles, a sgRNA designed from Optimized CRISPR
Design Tool (http://crispr.mit.edu/) and Cas9 were expressed using the PX459 vector (Addgene
plasmid #62988) and was transfected using Lipofectamine 3000 reagent (ThermoFisher
Scientific, L300015) along with a single stranded oligodeoxynucleotide (ssODN) of 140 base
pairs with homology arms flanking the mutation site carrying mutations for G118, a BamHI
restriction enzyme site for screening, along with a mutation to mutate the PAM sequence.
Individual clones were hand-picked for expansion and screening by PCR and sequencing.
Heterozygous clone 9-2 was expanded and transfected for targeting the second allele of
5
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
OPRM1 Exon 1. The two homozygous G118 knock-in clones were further subcloned before
expansion and freezing.
To convert rs1799971 in the 03SF subject iPS cell line from homozygous minor allele
(GG) to major allele (AA), a slightly different strategy was used. First, a CRISPR targeting site
was found using ZiFit software (16). The target site (GGCAACCTGTCCGACCCATG) included
the major allele sequence so the gRNA was designed to incorporate the minor allele
(GGCgACCTGTCCGACCCATG). A 200 nt homologous recombination donor oligo was
designed to convert minor to major allele, inactivate the CRISPR site, and introduce a HpaI site
for screening. The gRNA was synthesized by PCR and in vitro transcription (GeneArt Precision
gRNA Synthesis Kit, Life Technologies) (17), mixed with synthetic Cas9 protein (Life
Technologies), donor oligo, and the mixture was electroporated into iPS cells (Amaxa
nucleofector, Lonza) along with a GFP expression plasmid (pGFP-Max, Lonza). One day later,
cells were dissociated with Accutase and GFP-expressing cells were collected by FACS and
plated at about 5,000 cells per well in a 6-well plate on irradiated MEFs. By 7-10 days, colonies
were visible and hand-picked for screening. Three iPS cell clones were selected: C12, which
had no evidence of editing to be used as a negative control; D11 and A10, which both had
homozygous edits to produce rs1799971 major allele (AA). In all gene-targeted cell lines,
sequencing confirmed these edits and that all predicted off-target sites were unchanged.
Generation of GABAergic iN cells from human ES and iPS cells
The protocol of generating GABAergic human iN cells was described recently (18). Briefly, iPS
cells and ES cells were plated as dissociated cells on Matrigel ® Matrix (Corning Life Sciences)coated dishes in mTeSR (Stem Cell Technologies) medium with 2µM Y-27632 (Stemgent). The
following day, the cells are infected with Ascl1, Dlx2 and rtTA lentiviruses for 10-12 hours upon
which culture medium was replaced with Neurobasal medium (GIBCO by Life Technologies)
6
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
with B27 and L-Glutamine supplemented with 2µg/mL Doxycycline (MP Biomedicals) and 2µM
Y compound to induce TetO expression. The protocol for generating lentiviruses expressing
different transcription factors was previously described (18). Puromycin and Hygromycin
selection was conducted for the following 2 days, and on day 5, the iN cells are dissociated with
Accutase and plated on glass coverslips with a monolayer of passage three primary astrocytes
isolated from p1-3 pups, as described previously (15, 18, 19). Following plating, 50% of the
culture medium was replaced every 2-3 days with fresh Neurobasal media containing B27, LGlutamine, 100 ng/ml of BDNF, NT3 and GDNF.
Real-time RT-PCR (qPCR)
Total neuronal RNA from three independently generated batches of iN cells for each cell line
was prepared using TRIzol ® Reagent (Thermo Fisher Scientific), Human-specific Taqman
probes were purchased for OPRM1, MAP2, Tuj1, VGAT, GAD1, TH and PCR reaction
conditions followed the manufacturer’s recommendations. Undifferentiated iPS cells, ES cells,
and mouse astrocytes were used as negative controls. A sample of total RNA of a healthy
human brain as well as Human Thalamus from Biochain ® was used as a positive control.
Relative RQ values were obtained by normalizing expression levels to the C12 iN condition.
Student’s t-test was used to compare grouped N40 and D40 means.
Immunocytochemistry and confocal imaging
Inhibitory human neurons were fixed for 15 minutes in 4% paraformaldehyde in PBS and
permeabilized using 0.1% Triton X-100 in PBS for 10 minutes at room temperature. Cells were
then incubated in blocking buffer (4% bovine serum albumin with 1% normal goat serum in
PBS) for 1 hour at room temperature and then incubated with primary antibodies diluted in
blocking buffer for 1 hour at room temperature, washed with PBS three times, and subsequently
7
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
incubated in secondary antibodies for 1 hour at room temperature. Confocal imaging analysis
was performed using a Zeiss LSM700. Primary Antibodies used include: mouse anti Oct4
(Millipore Sigma MAB4401, 1:2000), mouse anti Tra-1-60 (Millipore Sigma MAB4360, 1:1000),
mouse anti MAP2 (Sigma-Aldrich M1406, 1:500), rabbit anti MAP2, (Sigma-Aldrich M3696,
1:500), rabbit anti Synapsin (e028, 1:3000), rabbit anti VGAT (Millipore Sigma AB5062P,
1:2000), mouse anti Gad-67 (Abcam ab26116, 1:500), mouse anti β3 Tubulin (BioLegend
801201, 1:2000).
Electrophysiology
Functional analyses of iN cells were conducted using whole cell patch clamp as described
elsewhere (15, 20). Briefly, a K-Gluconate internal solution was used, which consisted of (in
mM): 126 K-Gluconate, 4 KCl, 10 HEPES, 4 ATP-Mg, 0.3 GTP-Na2, 10 Phosphocreatine. The
pH was adjusted to 7.2 and osmolarity was adjusted to 270-290 mOsm. The bath solution
consisted of (in mM): 140 NaCl, 5 KCl, 2 CaCl 2, 2 MgCl2, 10 HEPES, 10 Glucose. The pH was
adjusted to 7.4. Spontaneous inhibitory postsynaptic currents (sIPSCs) were recorded at a
holding potential of 0mV under voltage-clamp mode. Miniature IPSCs were recorded in the
presence of tetrodotoxin (1 µM). Intrinsic action potential firing properties of the iN cells were
recorded in a bath solution containing 50 µM Picrotoxin and 20 µM CNQX. Evoked synaptic
currents were elicited using an extracellular concentric bipolar stimulating electrode positioned
approximately 100 µm away from the cell soma. All recordings were performed at room
temperature. Data presentation: All data are presented as mean ± S.E.M. Student’s t-test or 2way ANOVA were used to assess statistical significance.
8
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
RESULTS
Generation of human inhibitory neurons carrying N40D MOR variants
To investigate the functional role of the MOR N40D variant in a human neuronal context,
we obtained iPS cells from multiple individuals of European descent carrying homozygous
alleles for either MOR N40 (n=4) or MOR D40 (n=3) (Supplemental Fig. 1A). The rs1799971
genotype and the pluripotency of all seven iPS cell lines are confirmed by sequencing and
colocalized immunocytochemistry (ICC) for OCT4 and Tra-1-60 (Fig. 1A-B).
We derived inhibitory induced neuronal (iN) cells from all 7 iPS cell lines by lentiviral
mediated ectopic expression of the transcription factors Ascl1 and Dlx233. These induced
human neuronal cells express pan-neuronal makers including MAP2, β3-tubulin, and Synapsin
(Fig. 1C, Supplemental Fig. 1B) as well as inhibitory neuronal markers GAD67 and VGAT
(Fig. 1D, Supplemental Figs. 1C). Thus, the N40D SNP has no impact on MOR expression or
inhibitory neuronal identity. To examine whether the N40 and D40 iN cells are functionally
comparable under baseline conditions, we performed whole cell patch-clamp recordings of iN
cells after 5-6 weeks of re-plating onto a monolayer of mouse astroglia. The iN cells of both
genotypes exhibit similar intrinsic membrane excitability (Supplemental Fig. 1D-F) and can fire
repetitive spontaneous action potentials (APs) at baseline levels (Supplemental Fig. 1G-I) and
exhibit similar intrinsic excitability under baseline conditions (Fig. 1H-I). Similarly, no significant
differences in spontaneous or miniature inhibitory postsynaptic currents (sIPSCs and mIPSCs,
respectively) were observed by genotype (Figs. 1E-G, Supplemental Fig. 1J-L), indicating that
the N40D variant does not affect passive or active membrane properties and that the neurons
generated from subject iPS cell lines are of similar functional maturation and differentiation.
MOR D40 iN cells exhibit altered sensitivity to the MOR agonist DAMGO
9
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
There have been numerous studies7, 22-24, 28, 36-39 examining the functional consequences
of MOR N40D on receptor activation in overexpression models and in knock-in mice harboring
MOR N40D, but no functional or electrophysiological analyses on cultured neurons have been
conducted, specifically not in a human neuronal context. To gauge whether N40 and D40 iN
cells may respond differently to MOR activation, we used a MOR-specific agonist DAMGO ([DAla2, N-MePhe4, Gly-ol]-enkephalin) to study its role modulating synaptic release. In both N40
and D40 iN cells, DAMGO suppressed sIPSCs in a dose-dependent manner (Fig. 1K).
However, the suppression of sIPSC frequency was more robust in D40 iN cells compared to
N40 iN cells in multiple repeated experiments and multiple iPS cell lines (Fig. 1L), with no
difference in sIPSC amplitude by genotype. To confirm that the observation is not due to a
residual effect of prolonged agonist exposure, we applied a single concentration of 10µM
DAMGO (Fig. 1M-N) and similarly found that D40 iN cells respond more robustly to MOR
activation compared to N40 iN cells, illustrating genotype-dependent regulation of MOR
signaling.
Generation of isogenic human pluripotent stem cell lines carrying MOR N40D SNP
To directly compare the two MOR genotypes in identical genetic backgrounds,
eliminating the impact of secondary genetic variation, we generated two sets of isogenic human
stem cell lines using CRISPR/Cas9 gene targeting. We first targeted the MOR locus in a wellcharacterized human H1 ES cell line, which carries only major allele (A118), using an sgRNA
targeting the antisense DNA strand along with a 140bp single stranded oligodeoxynucleotide
carrying G118 (Fig. 2A-B). Simultaneously, we converted one iPS cell line with the homozygous
G118 allele to a homozygous A118 genotype with an alternative strategy utilizing direct
transduction of guide RNA and Cas9 protein into the subject cell line (Fig. 2C-D). We isolated
two clones (Supplemental Fig. 2A-C) with no detectable off-target effects from each targeting
10
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
scheme. Inhibitory iN cells generated from isogenic lines stain positive for MAP2, Synapsin and
VGAT (Fig. 2E-F) and exhibit similar intrinsic membrane properties (Supplemental Fig. 2D-E)
as well as sIPSC and AP properties in both genotypes (Supplemental Figs. 2F-G, 3A-C). The
densities and sizes of synapses were also not significantly different between genotypes
(Supplemental Fig. 2H-I), illustrating that the N40D SNP does not alter synaptogenesis or
functional maturation in the isogenic human neurons, and that the MOR N40D SNP has no
consequence on iN cell maturation or synaptic transmission at baseline levels.
Isogenic human neurons recapitulate differential DAMGO response phenotype and
exhibit altered synaptic function
In this highly controlled system of isogenic iN cells, we observed less culture-to-culture
variability than the subject cell lines for OPRM1 mRNA and inhibitory neuronal markers (Fig.
2G-I). Furthermore, we observed a similar decrease in sIPSC frequency compared to subject iN
cells following acute DAMGO application, with a stronger inhibition in D40 versus N40 iN cells,
and no effect on amplitude (Fig 2J-O). Furthermore, to determine whether the effect of DAMGO
was mediated by MOR, we applied Naltrexone, a broad spectrum MOR antagonist, and found
that the DAMGO-induced synaptic suppression could be reversed (Supplemental Fig. 2J-K).
Thus, the reproducibility of the DAMGO response phenotype illustrates that the D40 variant
alone explains the differential signaling and it is not due to secondary genomic variation.
We focused the remaining analyses on one pair of isogenic cell lines, C12 and A10, on
the basis of their consistent differentiation and maturation. We found that DAMGO application
more robustly decreases mIPSC frequency in D40 versus N40 iN cells, which no change in
mIPSC amplitude (Fig. 3A-C), which suggests DAMGO mediated decrease in synaptic release.
Consistent with the decrease in mIPSC frequency, we observed that DAMGO decreases
evoked IPSC amplitude more robustly in D40 iN cells compared to N40 iNs (Fig. 3D-E). This is
11
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
consistent with the hypothesis that MOR activation by DAMGO in human iN cells more robustly
decreases neurotransmitter release probability in D40 iN cells compared to N40 iN cells,
suggesting that the A118G SNP directly regulates synaptic function.
D40 MOR-expressing neurons exhibit a more robust decrease in excitability following
DAMGO compared to N40 iN cells
To understand whether the decreased synaptic release is compounded by decreased
intrinsic excitability, we examined the effect of DAMGO on induced AP firing in N40 and D40 iN
cells. We observed that 10 µM DAMGO induced D40 versus N40 iN cells to fire significantly
fewer APs (Fig. 4A-B), with no effect on AP amplitude, firing threshold (Fig. 4C-D) or other
properties including Time to reach peak or threshold (not shown). This is supported by an
immediate and more robust decrease in spontaneous AP firing frequency following DAMGO
application in D40 versus N40 iN cells (Fig. 4E), an effect which is sustained over the course of
several minutes (Fig. 4F). This sustained decrease in AP frequency is paralleled by a rapid
hyperpolarization of N40 and D40 iN cells (Fig. 4G). This effect was found to be significantly
more robust in D40 versus N40 iN cells in the first minute following DAMGO application. The
immediate drop in AP firing frequency and membrane potentials in iN cells suggests that this
may be occurring through a G-protein mediated signaling mechanism, which is activated
immediately following agonist binding (21). No differences in AP rise time, decay time or half
width were detected by DAMGO application (not shown). However, we observed a slight
trending increase in the after hyperpolarization potential in the D40 versus N40 iN cells (Fig.
4H-I), with no significant difference in firing threshold or AP half width (Fig. 4J-K). These data
indicate the functional differences between the two genotypes are at least partly mediated by a
preferential decrease in excitability in D40 versus N40 iN cells, likely mediated by alterations in
the G-protein coupled signaling cascade. Overall, these data suggest that DAMGO-induced
12
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
decrease in excitability is superimposed by a synapse-specific effect, i.e., a stronger reduction
in synaptic release probability mediated by presynaptic MOR at the nerve terminal in D40 MOR
inhibitory neurons.
DISCUSSION
Our study provides the first experimental evidence detailing the electrophysiological
consequences of the N40D SNP on MOR activation in its endogenous human neuronal context.
First, we generated iN cells from human subject-derived stem cells carrying homozygous alleles
for N40 MOR or D40 MOR and found that D40 MOR expressing iN cells exhibit stronger
inhibitory effects of MOR activation on synaptic release. Second, to validate the functional
consequences of the SNP in a system highly controlled for background genetic variation, we
used CRISPR/Cas9 mediated gene targeting to: 1) knock-in homozygous D40 alleles into H1ES
cells; 2) correct the homozygous D40 alleles in 03SF iPS cell subject line into N40 alleles, and
thus generated two sets of isogenic stem cell lines for highly controlled mechanistic analyses,
The isogenic iN cells not only recapitulated the DAMGO response phenotype of the patient iN
cells, but also revealed that the N40D SNP mediates a more robust decrease in excitability and
synaptic release.
Despite previous studies in knock-in mouse models and heterologous expression
systems, the precise molecular and cellular consequences of MOR N40D have remained
unclear, primarily due to species-specific and context-specific mechanisms in the modulation of
MOR signaling. For instance, rodent models and other expression systems have suggested that
the D40 allele confers a “gain-of-function” effect by causing increased potency for DAMGO and
other MOR agonists (7, 11, 12, 22). However, subsequent studies have reported that the D40
allele is associated with reduced mRNA and protein expression in multiple brain regions of
knock-in mice (10, 13) along with reduced antinociceptive responses to morphine (8), providing
13
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
support for a “loss-of-function” phenotype. These contradictory results strongly necessitate the
need for a human neuronal model to understand MOR function.
The novelty of our approach using human iN cells to investigate the synaptic pathology
of addiction is that these cells carry the genetic signatures of the subjects from whom they were
derived. Identifying identical DAMGO-mediated responses across multiple subject-derived and
CRISPR-edited cell lines generated using independently executed targeting strategies clearly
demonstrates that the observed effect is a direct consequence of only the MOR N40D variant.
Collectively, this overall approach of combining multiple patient lines with genome-engineered
isogenic lines to assess addiction-associated electrophysiological phenotypes has not been
fulfilled in previous work. Thus, we show the utility of disease modeling using stem cell derived
disease-relevant cell types as a framework to the field of addiction for conducting future
mechanistic analyses.
This study represents a significant advance in our understanding of the neurobiological
mechanisms underlying the human N40D MOR variant in a human neuronal context. Our study
provides direct evidence that common genetic variation encodes functional variation at the level
of synaptic transmission. The use of patient-derived stem cells to unravel the impact of OPRM1
gene variants may ultimately provide the necessary insight to develop patient-specific, precision
medical interventions for drug and alcohol dependence.
14
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
ACKNOWLEDGMENTS
We thank RUCDR Infinite Biologics for generating the iPS cells from human subjects and
assisting with CRISPR/Cas9 gene targeting on 03SF iPS cell line. Research is supported by
grants from NIH-NIAAA R01 AA023797 as well as Collaborative Studies on the Genetics of
Alcoholism/COGA 5U10AA008401-26. AH is supported by NIH-NIAAA NRSA F31AA024033.
We are grateful to the members of the Collaborative Genetic Study of Nicotine Dependence
(COGEND) for the selection of human subjects, and we are grateful to the de-identified
individuals who contributed tissue to the study.
DISCLOSURES
The authors declare they have no competing financial interests.
15
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
REFERENCES
1.
Centers for Disease Control and Prevention (2017): Opioid overdose: understanding the
epidemic.
2.
Contet C, Kieffer BL, Befort K (2004): Mu opioid receptor: a gateway to drug addiction.
Curr Opin Neurobiol. 14:370-378.
3.
Gerrits MA, Lesscher HB, van Ree JM (2003): Drug dependence and the endogenous
opioid system. Eur Neuropsychopharmacol. 13:424-434.
4.
Kauer JA, Malenka RC (2007): Synaptic plasticity and addiction. Nat Rev Neurosci.
8:844-858.
5.
Mague SD, Blendy JA (2010): OPRM1 SNP (A118G): involvement in disease
development, treatment response, and animal models. Drug Alcohol Depend. 108:172182.
6.
Kroslak T, Laforge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ (2007): The single
nucleotide polymorphism A118G alters functional properties of the human mu opioid
receptor. J Neurochem. 103:77-87.
7.
Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, et al. (1998): Single-nucleotide
polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and
activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 95:96089613.
8.
Mague SD, Isiegas C, Huang P, Liu-Chen LY, Lerman C, Blendy JA (2009): Mouse
model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated
behavior. Proc Natl Acad Sci U S A. 106:10847-10852.
9.
Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR, Kieffer BL (2001): A single
nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs
receptor signaling. J Biol Chem. 276:3130-3137.
10.
Beyer A, Koch T, Schroder H, Schulz S, Hollt V (2004): Effect of the A118G
polymorphism on binding affinity, potency and agonist-mediated endocytosis,
desensitization, and resensitization of the human mu-opioid receptor. J Neurochem.
89:553-560.
11.
Mahmoud S, Thorsell A, Sommer WH, Heilig M, Holgate JK, Bartlett SE, et al. (2011):
Pharmacological consequence of the A118G mu opioid receptor polymorphism on
16
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
morphine- and fentanyl-mediated modulation of Ca(2)(+) channels in humanized mouse
sensory neurons. Anesthesiology. 115:1054-1062.
12.
Margas W, Zubkoff I, Schuler HG, Janicki PK, Ruiz-Velasco V (2007): Modulation of
Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid
receptors (hMORs) containing the A118G single-nucleotide polymorphism. J
Neurophysiol. 97:1058-1067.
13.
Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W (2005): Allelic expression imbalance
of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem.
280:32618-32624.
14.
Moore JC, Sheldon MH, Hart RP (2012): Biobanking in the Era of the Stem Cell: A
Technical and Operational Guide. Morgan & Claypool Life Sciences.
15.
Oni EN, Halikere A, Li G, Toro-Ramos AJ, Swerdel MR, Verpeut JL, et al. (2016):
Increased nicotine response in iPSC-derived human neurons carrying the CHRNA5 N398
allele. Sci Rep. 6:34341.
16.
Sander JD, Maeder ML, Reyon D, Voytas DF, Joung JK, Dobbs D (2010): ZiFiT (Zinc
Finger Targeter): an updated zinc finger engineering tool. Nucleic Acids Res. 38:W462468.
17.
Liang X, Potter J, Kumar S, Zou Y, Quintanilla R, Sridharan M, et al. (2015): Rapid and
highly efficient mammalian cell engineering via Cas9 protein transfection. Journal of
biotechnology. 208:44-53.
18.
Yang N, Chanda S, Marro S, Ng YH, Janas JA, Haag D, et al. (2017): Generation of pure
GABAergic neurons by transcription factor programming. Nat Methods. 14:621-628.
19.
Maximov A, Pang ZP, Tervo DG, Sudhof TC (2007): Monitoring synaptic transmission in
primary neuronal cultures using local extracellular stimulation. J Neurosci Methods.
161:75-87.
20.
Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M (2010): Direct
conversion of fibroblasts to functional neurons by defined factors. Nature. 463:1035-1041.
21.
Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, et al.
(2013): Regulation of mu-opioid receptors: desensitization, phosphorylation,
internalization, and tolerance. Pharmacol Rev. 65:223-254.
22.
Lopez Soto EJ, Raingo J (2012): A118G Mu Opioid Receptor polymorphism increases
inhibitory effects on CaV2.2 channels. Neurosci Lett. 523:190-194.
17
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Figure Legends
Figure 1
MOR N40D expressing inhibitory human neurons exhibit more robust suppression of
inhibitory synaptic transmission by DAMGO. (A) Oct4 (green), Tra 1-60 (red), and Dapi
(blue) ICC for N40 and D40 subject iPS cells depicting pluripotency (B) Sequencing confirming
homozygous A118 or G118 genotype of human iPS cell lines (C) MAP2 (green) and Synapsin
(red) ICC of iN cells generated from N40 and D40 subject iPS cells (D) MAP2 (green) and
VGAT (red) ICC of induced inhibitory neuronal (iN) cells generated from N40 and D40 subject
iPS cells (E-G) Both N40 and D40 iN cells exhibit PTX sensitive spontaneous IPSCs whose
frequency (N40 vs D40: N.S.) and amplitude (N40 vs D40: N.S.) are unaffected by MOR N40D
substitution (H) Representative traces of action potentials induced by step current injections
(from -20 to +75 pA, 5pA increments) during current clamp recordings from one N40 and D40
cell line (I) Quantification of induced action potentials in inhibitory iNs cells illustrating that
neuronal excitability is unchanged as a consequence of MOR N40D (N40 vs D40: N.S. at all
current injections) (J) Representative traces of sIPSCs recorded to increasing concentrations of
DAMGO in N40 and D40 iN cells (K) Quantification of inhibition of sIPSC frequency in individual
subject derived N40 and D40 iN cells (L) Merged data of the four N40 and three D40 subject
lines illustrates that D40 iN cells exhibit stronger suppression of IPSC frequency compared to
N40 iN cells (M-N) sIPSC frequency response to a single concentration of 10µM DAMGO; data
is normalized to control (N40 vs control: p<0.001, D40 vs control: p<0.001). Summary graphs
are shown as individual cell lines or merged data of either four N40 patients (red bars) and three
D40 patients (blue bars) (N40 vs D40: p <0.01). Data are depicted as means ± SEM. Numbers
of cells/Number of independently generated cultures analyzed are depicted in bars. Statistical
significance between N40 and D40 was evaluated by Student’s T test (*p<0.05, **p<0.01,
***p<0.001).
Figure 2
Human neurons from two sets of independently targeted isogenic human stem cell lines
for OPRM1 A118G validate differential DAMGO response observed in patient cell lines.
(A) OPRM1 Targeting Strategy 1: Structure of OPRM1 gene on chromosome 6 and schematic
overview of CRISPR/Cas9 gene targeting strategy to knock-in homozygous G118 alleles into
human H1 embryonic stem cell (H1ES) in which sgRNA targets donor strand. In the 140bp
ssODN, we inserted a T to C mutation to incorporate OPRM1 GG118, synonymous G to A for
PAM mutation, and synonymous G to C and G to A mutations to create a BamHI restriction
18
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
enzyme site. (B) Sequencing of original H1ES control cell line carrying homozygous A118 (N40)
alleles, and two isolated clones carrying homozygous OPRM1 G118 (D40) alleles (Clone 9-217, Clone 9-2-18). (C) OPRM1 Targeting Strategy 2: Structure of OPRM1 gene on chromosome
6 and an independent CRISPR/Cas9 gene targeting strategy to correct 03SF patient line
(originally homozygous G118 expressing MOR D40) to homozygous A118 (N40). We designed
a 200 nt template strand to knock-in homozygous A118 alleles, containing mutations to
generate a HpaI restriction enzyme site for screening (D) Sequencing of passage-matched,
uncorrected 03SF patient cell line carrying homozygous D40 alleles (C12) and two genecorrected clones (Clone A10, D11) carrying homozygous OPRM1 A118 (N40) alleles after
subcloning. (E) ICC of MAP2 (green) and Synapsin (red) of iN cells produced from genetargeted ES cells and iPS cells. (F) Immunofluorescence of MAP2 (green) and VGAT (red) of iN
cells produced from gene-targeted ES cells and iPS cells. (G-I) Relative mRNA levels of
OPRM1 as well as markers inhibitory subtype specificity (GAD1, VGAT) measured by
quantitative RT-PCR; mRNA levels are normalized to Synapsin I. Data are represented as
means of three independently differentiated batches of iNs from each patient iPS cell line. (J)
Representative traces of sIPSCs recorded to increasing concentrations of DAMGO in N40 and
D40 iN isogenic iN cells derived from ES cells. (K-L) Quantification of sIPSC frequency (H1 vs
control: p<0.05, Clone 17 vs control: p < 0.001, Clone 18 vs control: p <0.001, N40 vs control: p
< 0.05, D40 vs control: p <0.001, N40 vs D40: p <0.05) and amplitude in response to 6µM
DAMGO (H1 vs control: N.S., Clone 17 vs control: N.S., Clone 18 vs control: N.S., N40 vs
control: N.S., D40 vs. control: N.S., N40 vs D40: N.S.) (M) Representative traces of sIPSCs
recorded to increasing concentrations of DAMGO in N40 and D40 iN isogenic iN cells derived
from iPS cells. (N-O) Quantification of sIPSC frequency (A10: DAMGO vs control: p<0.01, D11:
DAMGO vs control: N.S., C12: DAMGO vs control: p <0.001, N40: DAMGO vs control: p<0.01,
D40: DAMGO vs control: p<0.001, N40 vs D40: p <0.05) and amplitude in response to 6µM
DAMGO (A10: DAMGO vs control: N.S., D11: DAMGO vs control: N.S., C12: DAMGO vs
control: N.S., N40: DAMGO vs control: N.S., D40: DAMGO vs. control: N.S., N40 vs D40: N.S.).
Data are depicted as means ± SEM. Numbers of cells/Number of independently generated
cultures analyzed are depicted in bars. Statistical significance was evaluated by Student’s t test
(* p<0.05, **p<0.01, *** p<0.001).
Figure 3
D40 iN cells exhibit greater inhibition of synaptic release and intrinsic excitability. (a)
Representative traces of mIPSCs in one N40 (A10) and one D40 (C12) cell line derived iN cells
19
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
recorded at 0mV holding potential and their response to DAMGO. (b-c) Quantification of mIPSC
frequency (A10: DAMGO vs control p < 0.01, C12: DAMGO vs control p < 0.001) and amplitude
(A10 and C12: DAMGO vs control p > 0.05) in A10 and C12 iN cells normalized to before
DAMGO application. (DAMGO effect on frequency: A10 vs C12: p < 0.05, DAMGO effect on
amplitude: A10 vs C12: N.S.) (d) Representative traces of evoked IPSCs from one N40 (A10)
and one D40 (C12) cell line derived iN cells (e) Quantification of evoked IPSC amplitude in A10
and C12 iN cells normalized to before DAMGO application (A10: DAMGO vs control p < 0.05,
C12: DAMGO vs control p < 0.001, A10 vs C12: p<0.001). Data are depicted as means ± SEM.
Numbers of cells/Number of independently generated cultures analyzed are depicted in bars.
Statistical significance was evaluated by Student’s t test (*p<0.05, **p<0.01, ***p<0.001).
Figure 4
D40 iN cells exhibit a sustained decrease in intrinsic excitability. (a) Representative traces
of repetitive action potentials generated from depolarizing current injections in one N40 (A10)
cell line derived iN and one D40 (C12) cell line derived iN, and their response to DAMGO (b-d)
Summary graphs of DAMGO effect on AP Number (A10: DAMGO vs control: N.S., C12:
DAMGO vs control p<0.001), Amplitude (A10: DAMGO vs control p<0.01, C12: DAMGO vs
control p<0.001) and firing threshold (A10: DAMGO vs control: N.S., C12: DAMGO vs control:
N.S.). Data normalized to before DAMGO application reveals DAMGO preferentially decreases
intrinsic excitability of D40 iNs but not N40 iNs (DAMGO effect on Frequency: A10 vs C12
p<0.01) with no effect on Amplitude (A10 vs C12: N.S.) or Firing Threshold (A10 vs C12: N.S.)
(e) Representative traces depicting the effect of DAMGO on spontaneous action potential firing
in one D40 (C12) and one N40 (A10) cell line derived iN (f) Quantification of number of
spontaneous action potentials fired before and after DAMGO application in N40 and D40 iNs
represented as a timecourse (g) Quantification of resting membrane potential before and after
DAMGO application in N40 and D40 iNs represented as a timecourse (h) Representative traces
of individual Action Potentials before and after DAMGO in N40 and D40 iN cells (i-k) Summary
graphs depicting that DAMGO causes a trending increase in the AHP amplitude in D40 iN cells
compared to N40 iN cells (A10: DAMGO vs control: N.S., C12: DAMGO vs control: p<0.05, A10
vs C12: N.S.) with no effect on Firing threshold (A10: DAMGO vs control: N.S., C12: DAMGO vs
control: N.S., A10 vs C12: N.S.) or half width (A10: DAMGO vs control: N.S., C12: DAMGO vs
control: N.S., A10 vs C12: N.S.). Data are depicted as means ± SEM. Numbers of cells/Number
of independently generated cultures analyzed are depicted in bars. Statistical significance was
evaluated by Student’s t test (*p<0.05, **p<0.01, ***p<0.001).
20
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Supplemental Information:
Addiction associated N40D mu-opioid receptor variant modulates synaptic function in
human neurons
Apoorva Halikere1,2, Dina Popova1,2, Aula Hamod1,2, Mavis R. Swerdel5, Jennifer C. Moore3,4,
Jay A. Tischfield3,4, Ronald P. Hart3,5, Zhiping P. Pang1,2,3*
1
Child Health Institute of New Jersey, 2 Department of Neuroscience and Cell Biology, Rutgers
Robert Wood Johnson Medical School, 3 Human Genetics Institute of New Jersey, 4
Department of Human Genetics, 5 Department of Cell Biology and Neuroscience, Rutgers
University
*Correspondence to:
Zhiping Pang,
Child Health Institute of New Jersey, Rutgers University,
89 French Street, Room 3277
New Brunswick, NJ 08901,
Phone: (732)-235-8074, Fax: (732)-235-8612,
Email: zhiping.pang@rutgers.edu
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Supplementary Figure 1:
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Supplementary Figure 1 OPRM1 N40D SNP does not impair intrinsic neuronal parameters
of iN cells, inhibitory neuronal differentiation, or neuronal function. (A) iPS cell lines
generated by RUCDR Infinite Biologics from individuals carrying A118G SNPs are homozygous
for SNPs in other genes linked to addiction. (B) MAP2 and βIII-tubulin ICC of inhibitory iN cells
differentiated from human iPS cell subject lines to illustrate expression of markers of neuronal
maturation (C) MAP2 and GAD67 immunofluorescence of inhibitory iN cells differentiated from
human iPS cell subject lines to illustrate inhibitory subtype (D-F) N40 and D40 iPS cell derived
iN cells exhibit similar intrinsic membrane properties including capacitance (N40 vs D40: N.S.),
input resistance (N40 vs D40: N.S.), and resting membrane potential (N40 vs D40: N.S.),
illustrating similar maturation status (G-I) Representative traces of spontaneous action
potentials recorded from one A118 (N40) and one G118 (D40) iN cells. Summary graphs
illustrate that N40 and D40 iNs exhibit similar spontaneous action potential firing frequency (N40
vs D40: N.S.) and amplitude (N40 vs D40: N.S.) (J-L) Frequency (N40 vs D40: N.S.) and
amplitude (N40 vs D40: N.S.) of miniature IPSCs in iN cells are unaffected by MOR N40D
substitution (M-O) Relative mRNA levels of OPRM1 (N40 vs D40: N.S.) as well as markers of
neuronal maturation including MAP2 (N40 vs D40: N.S.) and Tuj1 (N40 vs D40: N.S.) measured
by quantitative RT-PCR; mRNA levels are normalized to Synapsin I. Data are represented as
means of three independently differentiated batches of iNs from each patient iPSC line.
Summary graphs of these parameters are shown as merged data of either four N40 patients or
three D40 patients. Data are depicted as means ± SEM. Numbers of cells/Number of
independently generated cultures analyzed are depicted in bars. Statistical significance was
evaluated by Student’s t-test (* p<0.05, ** p<0.01, *** p<0.001)
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Supplementary Figure 2:
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Supplementary Figure 2 Characterization of CRISPR/Cas9 gene targeted isogenic cell
lines. (A) Oct4 (green) and Dapi (blue) immunofluorescence for H1ES and 03SF gene-targeted
clones depicting pluripotency (B) Tra-1-60 (red) and Dapi (blue) immunofluorescence for H1ES
and 03SF gene-targeted clones depicting pluripotency (C) Sequencing of original H1ES control
and two homozygous MOR D40 lines confirming homozygous knock-in of either N40 alleles or
D40 alleles. (D) N40 and D40 isogenic iN cells from H1 ES cells exhibit similar intrinsic
membrane properties including capacitance (N40 vs D40: N.S.) and input resistance (N40 vs
D40: N.S.) at baseline levels, illustrating similar maturation status (E) N40 and D40 isogenic iN
cells from 03SF iPS cell line exhibit similar intrinsic membrane properties including capacitance
(N40 vs D40: N.S.) and input resistance (N40 vs D40: N.S.) at baseline levels, illustrating similar
maturation status (F-G) Both N40 and D40 iN cells exhibit sIPSCs; Frequency (H1 ES cell
isogenic lines: N40 vs D40: N.S., 03SF iPS cell isogenic lines: N40 vs D40: N.S.) and amplitude
(H1 ES cell isogenic lines: N40 vs D40: N.S., 03SF iPS cell isogenic lines: N40 vs D40: N.S.) of
sIPSCs in iN cells are unaffected by MOR N40D substitution (H-I) Synapse area (H1 ES cell
isogenic lines: N40 vs D40: N.S., 03SF iPS cell isogenic lines: N40 vs D40: N.S.) and Synapsin
puncta density (H1 ES cell isogenic lines: N40 vs D40: N.S., 03SF iPS cell isogenic lines: N40
vs D40 p<0.001) normalized to MAP2 area are unaffected by MOR N40D substitution (J-K)
Naltrexone reverses the DAMGO synaptic inhibition phenotype in both N40 and D40 iN cells
(N40 Effect on Frequency: DAMGO vs control p < 0.05, Naltrexone vs control: N.S., D40 Effect
on Frequency: DAMGO vs control p <0.001, Naltrexone vs control: N.S.) with no effect on
amplitude (N40 Effect on Amplitude: DAMGO vs control: N.S., Naltrexone vs control: N.S., D40
Effect on Amplitude: DAMGO vs control: N.S., Naltrexone vs control: N.S.). Data are presented
as mean ± SEM, Numbers of cells/Number of independently generated cultures analyzed are
depicted in bars. Student’s t-tests were used for statistics.
bioRxiv preprint doi: https://doi.org/10.1101/328898. this version posted August 6, 2018. The copyright holder for this preprint (which was not
certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Supplementary Figure 3:
Supplementary Figure 3 MOR N40D SNP does not impair action potential properties in
N40 and D40 iN cells at baseline levels
(A) Representative traces of spontaneous action potentials fired by A10 (N40) iN cells and C12
(D40) iN cells (B) Quantification of action potential properties at baseline levels between A10
(N40) and C12 (D40) iN cells shows N40D does not alter Spontaneous AP frequency (A10 vs
C12: N.S.), amplitude (A10 vs C12: N.S.), threshold (A10 vs C12: N.S.), time to peak (A10 vs
C12: N.S.), resting membrane potential (A10 vs C12: N.S.), and half width (A10 vs C12: N.S.)
(C) Quantification of action potential rise and decay kinetics at baseline levels between A10
(N40) and C12 (D40) iN cells shows N40D does not alter Rise Time (A10 vs C12: N.S.), Decay
time (A10 vs C12: N.S.), Rise slope (A10 vs C12: N.S.), or decay slope (A10 vs C12: N.S.).
Data are depicted as means ± SEM. Numbers of cells/Number of independently generated
cultures analyzed are depicted in bars. Statistical significance between N40 and D40 was
evaluated by Student’s t-test (*p<0.05, **p<0.01, ***p<0.001)